March 22 – 23, 2018
Philadelphia, PA, USA
This training will examine the differences between Quality Assurance and Quality Control and the responsibilities of each. In addition, attendees will discuss what characteristics quality personnel should possess. The current expectations for an effective quality system program as defined in both the FDA and EU requirements and guidance documents will be reviewed. Topics to be covered will range from the development of a quality manual and procedures, the importance and scope of audits (internal, vendor, third party and regulatory) along with review of various case studies to help further illustrate points discussed.
The quality department within companies is responsible for nearly all activities to various degrees that have impact on the quality, safety or efficacy of the final product or material produced. It is also responsible for helping assure that contracted services, which is more common today than ever before, are also verified to meet the quality standards set both by the company and the regulatory requirements. The training will review special topics of interest to auditors such as CAPA programs and investigations that address deviations and Out of Specification (OOS) results. Attendees will be given ample opportunity to ask questions, discuss actual case studies and to learn about the vast scope of responsibility that the quality system regulations expect and the roles of their own positions.SEM9002
Areas Covered in the Session :
- Understand the regulatory expectations of the quality unit and its role in the Quality System Requirements (QSR)
- Review the Quality areas that are the point of focus during regulatory, corporate or third party audits.
- Review typical checklist that can be used as a template for the performance of audits
- Evaluate the importance of training, its documentation, and common concerns being raised over “operator error”
- Review the importance and regulatory guidance offered for the investigation of deviations/out-of-specification results.
- Review the current focus on data integrity issues and the current guidance document regarding it
- Review the top 10 most commonly cited drug GMP deficiencies for 2015-2016
- Understand the weaknesses of each person’s current quality system and discuss possible recommended corrective actions
Who Should Attend :
This course is designed for people within the quality unit, those impacted by quality requirements, third party suppliers who are evaluated against quality issues and their adherence to them, along corporate management who is required to provide the time and resources to correct quality issues identified. This includes individuals that have Quality Management Systems responsibilities for making general improvements in their organization’s performance. Following personnel will benefit from the course:
- Senior quality managers
- Quality professionals
- Regulatory professionals
- Compliance professionals
- Production supervisors
- Manufacturing engineers
- Production engineers
- Design engineers
- Process owners
- Quality engineers
- Quality auditors
- Document control specialists
DAY 1 (8:30 AM – 4:30 PM):
Registration Process – (8:30 AM – 8:45 AM)
- Review of Regulatory requirements for the quality organization within companies. Will examine current FDA (21 CFR parts 210-211 and 820), EU and Health Canada requirements.
- Discuss the importance of audits as a means of assuring compliance and the ability of the Quality System to meet its responsibilities.
- Review importance of internal and vendor audits and provide a checklist of items to be covered and reviewed.
- Discuss expectations for applicable procedures covering these topics.
- Discuss audit techniques that will help assure successful results when preparing for audits.
- Review current industry guidelines for the investigation of “Out-of-Specification” (OOS) laboratory results.
DAY 2 (8:30 AM – 4:30 PM):
- Discuss areas of concern and focus during laboratory audits.
- Review importance and requirements for personnel training.
- Discuss current concerns by FDA and EU auditors regarding “operator error” when listed as the “root cause” for deviation investigations.
- Review importance and requirements for vendor evaluations and quality agreements. What to look for, what to be included, etc. Discuss actual case studies as to actions taken by vendors and their potential impact on component, service or product quality.
- Discuss importance of CAPA process and change control programs that help maintain compliance and prevent occurrences of deviations.
- Review the 10 most common drug GMP deficiencies cited by the FDA inspectors during 2015-2016. Learn what quality systems are found most deficient.
Each day’s training will include actual case studies to highlight topics covered, review of applicable forms that can be used as templates for change control, or audit checklists, etc. Attendees will have ample opportunity to ask questions regarding current industry practices or their own company practices.
President, VTS Consultants
Mr. Christie was the Validation Manager at Parke-Davis’ Sterile Products Facility where he was involved in the review and approval of all facilities, equipment, and system commissioning/qualification activities. He had routine interaction with the FDA and European inspectors (EMEA), corporate management and third party contract-manufacturing representatives to defend validation practices and to assure regulatory compliance for the manufacture of aseptically produced products.
Mr. Christie is a speaker and trainer for several professional organizations in the US, Canada, Europe, and Asia and is a published author of several articles dealing with the challenges of aseptic processing. Additionally, Mr. Christie served as a member of the ISPE’s Professional Certification (PCC) Commission as an Examination Development Committee (EDC) member.
He possesses a BS degree in Biology from Shippensburg State University (PA) and an Executive MBA degree from Michigan State.
- Make Secure Payment using Credit Card
- Click on Register Now, and you will be redirected to Payment Options page.
- Please choose your option (No. of delegates) from the drop down and click on Add to basket
- Click on Proceed to Checkout on the Cart Page, and complete the registration.
- Once the payment is completed, you will be receiving a Form to fill up the Delegates Information
- An electronic event pass (eTicket) will be sent to the email addresses associated with the registered delegates, 5 working days before the seminar date.
- Please bring the respective passes to the event venue.
Pay by Wire:
- Please contact our support to assist you with registration by Wire
- Support Number: +1-416-915-4458
- E-mail: firstname.lastname@example.org
- Pay your check to (payee name) “FutureCorp Consulting Inc” our parent company
- Please send the Scanned copy of the check to email@example.com
- Mail the check to:
FutureCorp Consulting Inc
5969, Candlebrook Ct.,
Mississauga, ON L5V 2V5,
- Once we receive the check, you will be receiving a Form to fill up the Delegates Information
- After payment receipt, from the registered attendee, an electronic event pass (eTicket) will be sent to the email addresses associated with the registered delegates, 5 working days before the seminar date. Please bring the respective passes to the event venue.
Philadelphia, PA, USA
(Venue to be announced shortly)
March 22 – 23, 2018
Call for Assistance: +1-416-915-4458